Follow
Gelmetix Ltd
Nasdaq First North GM (Sweden)
Gelmetix develops multiple grades of polymer gel to provide affordable non-invasive alternatives to surgery for conditions like chronic lower back pain and osteoarthritis. Our goal is to become a diversified solution-platform and to subsequently develop and in-license different families of products.
Current instruments
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
Nasdaq First North GM
Sweden (SE)
Details of share in Gelmetix Ltd with ticker
Status
Active
Order book id
Amount of instruments
Par value
Market cap
Currency
Terms
Type
Price
Pre-money valuation
Time
Files
Listing
2020
-
Direct listing of Gelmetix Ltd on Nasdaq First North GM
People
Philippe Jenny
CEO
Michael Fiore
Chairman of the board
Philippe Jenny
Board member
Sam Bakri
Board member
Tony Freemont
Board member
Gerard De Geer
Board member
Navin Khattar
Board member
Company Details
Sector

Address
Alderley Park, Nether Alderley
Zip code
SK10 4TG
City/district
Cheshire
Country
United Kingdom (GB)
Phones
Registration number
8146622
LEI code
First trade date
Company former names
Gelexir Healthcare Limited
20 Aug 2018
Registration date
17 Jul 2012
Short name
Gelmetix

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date